0001193125-12-060360.txt : 20120214
0001193125-12-060360.hdr.sgml : 20120214
20120214151337
ACCESSION NUMBER: 0001193125-12-060360
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20111231
FILED AS OF DATE: 20120214
DATE AS OF CHANGE: 20120214
EFFECTIVENESS DATE: 20120214
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: BROOKSIDE CAPITAL MANAGEMENT LLC
CENTRAL INDEX KEY: 0001156175
IRS NUMBER: 043517087
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-06625
FILM NUMBER: 12608461
BUSINESS ADDRESS:
STREET 1: JOHN HANCOCK TOWER
STREET 2: 200 CLARENDON STREET
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 617-516-2000
MAIL ADDRESS:
STREET 1: JOHN HANCOCK TOWER
STREET 2: 200 CLARENDON STREET
CITY: BOSTON
STATE: MA
ZIP: 02116
13F-HR
1
d296221d13fhr.txt
FORM 13F
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 13F
Form 13F COVER PAGE
Report for the Calendar Year or Quarter Ended: December 31, 2011
Check here if Amendment [_]; Amendment Number: __________
This Amendment (Check only one.): [_] is a restatement.
[_] adds new holdings entries.
Institutional Investment Manager Filing this Report:
Name: Brookside Capital Management, LLC*
Address: John Hancock Tower
200 Clarendon Street
Boston, Massachusetts 02116
Form 13F File Number: 28-06625
The institutional investment manager filing this report and the person by whom
it is signed hereby represent that the person signing the report is authorized
to submit it, that all information contained herein is true, correct and
complete, and that it is understood that all required items, statements,
schedules, lists, and tables, are considered integral parts of this form.
Person Signing this Report on Behalf of Reporting Manager:
Name: William E. Pappendick IV
Title: Managing Director
Phone: (617) 516-2000
Signature, Place, and Date of Signing:
/s/ William E. Pappendick IV Boston, MA 2/14/2012
_______________________ ________________________ _______________________
[Signature] [City, State] [Date]
* Brookside Capital Management, LLC is the general partner of Brookside Capital
Investors, L.P., which is the general partner of Brookside Capital Partners
Fund, L.P. Brookside Capital Management, LLC is also the general partner of
Brookside Capital Investors II, L.P., which is the general partner of Brookside
Capital Trading Fund, L.P.
Report Type (Check only one.):
[X] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager
are reported in this report.)
[_] 13F NOTICE. (Check here if no holdings reported are in this report, and all
holdings are reported by other reporting manager(s).)
[_] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this
reporting manager are reported in this report and a portion are reported by
other reporting manager(s).
Form 13F SUMMARY PAGE
Report Summary:
Number of Other Included Managers: 4
-------------
Form 13F Information Table Entry Total: 48
-------------
Form 13F Information Table Value Total: 4,166,819
-------------
(thousands)
List of Other Included Managers:
Provide a numbered list of the name(s) and Form 13F file number(s) of all
institutional investment managers with respect to which this report is filed,
other than the manager filing this report.
No. Form 13F File Number Name
1 28-06924 Brookside Capital Investors, L.P.
2 28-06946 Brookside Capital Partners Fund, L.P.
3 28-13491 Brookside Capital Trading Fund, L.P.
4 28-13492 Brookside Capital Investors II, L.P.
Brookside Capital Management, LLC
FORM 13F INFORMATION TABLE AS OF 12/31/11
VOTING
INVESMENT OTHER AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP MARKET VALUE LONG SHARES DISCRETION MANAGERS SOLE SHARED NONE
ACME PACKET INC COM 004764106 53,028,423 1,715,575 X
AKAMAI TECHNOLOGIES INC COM 00971T101 168,913,428 5,232,758 X
ALLOT COMMUNICATION INC COM M0854Q105 46,839,545 3,081,549 X
ANHEUSER-BUSCH INBEV ADR 03524A108 27,665,064 453,600 X
APPLE INC COM 037833100 215,641,440 532,448 X
ARIAD PHARMACEUTICALS INC COM 04033A100 24,500,000 2,000,000 X
ARIBA INC COM 04033V203 33,965,371 1,209,593 X
BROADCOM CORP CL A 111320107 106,051,579 3,612,111 X
CHECK POINT SOFTWARE COM M22465104 196,853,299 3,746,732 X
CIENA CORP COM 171779309 94,866,602 7,840,215 X
CTRIP.COM INTERNATIONAL ADR 22943F100 132,791,139 5,674,835 X
EL PASO CORPORATION COM 28336L109 233,871,345 8,802,083 X
EMC CORP COM 268648102 290,967,274 13,508,230 X
EXPRESS SCRIPTS INC COM 302182100 162,603,090 3,638,467 X
FOSSIL INC COM 349882100 54,684,913 689,074 X
GOLAR LNG LTD BERMUDA SHS G9456A100 58,424,058 1,314,377 X
GOLDMAN SACHS GROUP INC COM 38141G104 94,741,160 1,047,674 X
GREEN MTN COFFEE ROASTERS IN COM 393122106 41,306,850 921,000 X
HOME INNS & HOTELS MGMT INC SPON ADR 43713W107 31,517,383 1,221,604 X
IDENIX PHARMACEUTICALS INC COM 45166R204 81,801,938 10,987,500 X
JINKOSOLAR HOLDNGS INC SPONSORED ADR 47759T100 4,914,125 982,825 X
KINDER MORGAN INC COM 49456B101 90,914,994 2,826,080 X
LAS VEGAS SANDS CORP COM 517834107 98,466,927 2,304,398 X
LYONDELLBASELL INDUSTRIES N SHS - A - N53745100 81,769,370 2,516,755 X
MACYS INC COM 55616P104 104,243,667 3,239,393 X
MAP PHARMACEUTICALS COM 56509R108 39,503,757 2,999,526 X
MATTERSIGHT CORP COM 577097108 2,260,044 486,031 X
MEAD JOHNSON NUTRITION CO COM 582839106 103,671,164 1,508,383 X
MELCO CROWN ENTMT LT ADR 585464100 58,039,663 6,033,229 X
MICHAEL KORS HLDGS LTD COM G60754101 224,845,445 8,251,209 X
MONSANTO CO SHS 61166W101 98,732,274 1,409,052 X
NANOSPHERE INC COM 63009F105 5,262,865 3,580,180 X
NEOPHOTONICS CORP COM 64051T100 572,500 125,000 X
NEWS CORP CL A 65248E104 107,038,180 5,999,898 X
POLYPORE INTL IN COM 73179V103 54,286,343 1,234,061 X
SEADRILL LIMITED SHS G7945E105 14,664,432 441,966 X
STANLEY BLACK & DECKER INC COM 854502101 105,626,420 1,562,521 X
STREAM GLOBAL SVCS IN COM 86323M100 4,137,500 1,250,000 X
TEKELEC COM 879101103 70,651,017 6,463,954 X
TRANSDIGM GROUP INC COM 893641100 35,206,126 367,957 X
TYCO INTERNATIONAL LTD SHS H89128104 102,563,623 2,195,753 X
UNITEDHEALTH GROUP INC COM 91324P102 43,921,265 866,639 X
VERIFONE SYS INC COM 92342Y109 95,379,618 2,685,237 X
VERTEX PHARMACEUTICALS INC COM 92532F100 113,484,481 3,417,178 X
VMWARE INC CL A CO 928563402 68,124,208 818,899 X
VONAGE HLDGS CORP COM 92886T201 16,588,847 6,770,958 X
YANDEX N V SHS CLASS A N97284108 46,039,984 2,337,055 X
YOUKU COM INC SPONSORED ADR 98742U100 224,876,539 14,350,762 *** X
***Ownership represents 1,862,857 ADS plus 224,782,288 ordinary shares
convertible to ADS on an 18:1 basis***